Efficacy and safety of combined pegylated interferon/ribavirin therapy in the management of rheumatological manifestations of chronic HCV patients

Citation:
El-Garf, A., S. Fawzy, F. Talaat, and M. abd elaziz, "Efficacy and safety of combined pegylated interferon/ribavirin therapy in the management of rheumatological manifestations of chronic HCV patients", The Egyptian Rheumatologist (Elsevier), vol. 38, pp. 35-39, 2016.